Acadian Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-178,839
| Closed | -$521K | – | 1580 |
|
|
2024
Q4 | $521K | Buy |
178,839
+165,468
| +1,238% | +$482K | ﹤0.01% | 1064 |
|
|
2024
Q3 | $34K | Buy |
+13,371
| New | +$34K | ﹤0.01% | 1898 |
|
|
2023
Q2 | – | Sell |
-6,070
| Closed | -$45K | – | 1697 |
|
|
2023
Q1 | $45K | Sell |
6,070
-224,735
| -97% | -$1.67M | ﹤0.01% | 1526 |
|
|
2022
Q4 | $2.33M | Buy |
230,805
+195,443
| +553% | +$1.97M | 0.01% | 647 |
|
|
2022
Q3 | $348K | Buy |
35,362
+1,169
| +3% | +$11.5K | ﹤0.01% | 1086 |
|
|
2022
Q2 | $365K | Buy |
34,193
+5,070
| +17% | +$54.1K | ﹤0.01% | 1064 |
|
|
2022
Q1 | $283K | Buy |
+29,123
| New | +$283K | ﹤0.01% | 1131 |
|